POTENTIAL ALZHEIMER'S DRUG DISAPPOINTS

May 07, 2013

By AM740 Staff

Share on

There’s disappointing news about a potential Alzheimer’s drug.

Baxter International says a blood product it was testing failed to slow mental decline or to preserve physical function in a major study of 390 patients with mild to moderate Alzheimer’s disease.

Excitement about the drug, Gammagard, grew last summer, when researchers reported the drug had stabilized Alzheimer’s disease for as much as three years in four patients.

 

 

 

Join Our Fan Club
Coverage Area
Downtown Toronto
96.7FM
Toronto HD
96.3 HD-2
Kingston to Windsor, Parry Sound to Pittsburgh
AM740
ZoomerRadio Logo

Recently Played: